The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the usage of testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of diseases affecting the testes, pituitary and hypothalamus, it hasn't been approved for treating age-related declines in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the safety of testosterone. The study involved nearly 800 elderly men with low testosterone and symptoms associated with this condition, for example http://tinyurl.com/jrdad8y sexual and physical dysfunction. The research is anticipated to shed more light on the security of testosterone treatment since the heart health of the men was carefully monitored.
The recent conflicting findings on testosterone therapy prompted Patel and his team to run a sizeable systematic literature search for studies assessing the relationship between testosterone replacement therapy and cardiovascular events among guys. An estimated 13 million men in the United States have problems with low testosterone, which occurs when the body fails to make enough hormones because of a problem with the testicles or pituitary gland. This describes the unexpected weight gain, clear aging and decline of energy of an individual.
And many women have a knee-jerk suspicion that any hormone treatment can increase their risk of breast cancer. However, clinical studies show that testosterone not only doesn't increase a woman's risk of breast cancer , it may play a key role in warding off the disease. Glaser thinks this will likely stay the status quo for a little while, given the prohibitive cost of running the long term safety studies needed to acquire completer FDA approval.